Arcutis Biotherapeutics (ARQT)
(Delayed Data from NSDQ)
$9.10 USD
-0.58 (-5.99%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $9.09 -0.01 (-0.11%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/01/2024
Time: -- |
9/2024 | $-0.40 | -4.13% |
Earnings Summary
For their last quarter, Arcutis Biotherapeutics (ARQT) reported earnings of -$0.42 per share, beating the Zacks Consensus Estimate of $-0.48 per share. This reflects a positive earnings surprise of 12.50%. Look out for ARQT's next earnings release expected on November 01, 2024. For the next earning release, we expect the company to report earnings of -$0.40 per share, reflecting a year-over-year increase of 45.21%.
Earnings History
Price & Consensus
Zacks News for ARQT
Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Lags Revenue Estimates
ARQT: What are Zacks experts saying now?
Zacks Private Portfolio Services